Pearson R K, Anderson B, Dixon J E
Division of Gastroenterology and Internal Medicine, Mayo Medical Center, Rochester, Minnesota.
Endocrinol Metab Clin North Am. 1993 Dec;22(4):753-74.
The application of recombinant molecular biology has lead to remarkable advances in our understanding of the basic mechanisms of cell function in general and of the polarized GI endocrine cell in particular. This article focuses on some of the advances made towards determining the contribution of peptide hormone gene regulation to the regulation of physiological events in the GI tract. Application of these techniques to other subcellular processes involved in peptide hormone physiology such as subcellular trafficing in the regulated secretory pathway and post-translational processing have been equally impressive. For example, many of the key enzymes in the peptide hormone processing cascade have been cloned and are being studied at a molecular level. We have focused this article on the SS and gastrin peptides because of their known physiologic importance and interactions, and the depth of analysis accomplished to date. Studies using SS and gastrin as models have established principals that cover the spectrum of luminal regulation of gene activity to the identification of a single amino acid residue responsible for cAMP induction of SS gene expression. Many genes in the GI endocrine system have been cloned and the article by Dr. Habener (elsewhere in this issue) discusses progress made in understanding the complex regulation of the glucagon gene. We anticipate similar advances in studies of cholecystokinin, secretin, motilin, VIP, pancreatic polypeptide, and neuropeptide Y, whose genes have been cloned and initially characterized. Finally, as outlined in this article, the mechanisms of regulation of a specific gene often differ between sites of expression, even within the GI tract. Direct studies of the subcellular mechanisms regulating gene expression and other processes in GI endocrine cells await novel methods to maintain and propagate these cells. These studies will almost certainly involve new and creative uses of recombinant molecular biology.
重组分子生物学的应用使我们对细胞功能的基本机制,尤其是极化胃肠道内分泌细胞的基本机制有了显著的认识进展。本文重点介绍了在确定肽激素基因调控对胃肠道生理事件调节的贡献方面所取得的一些进展。将这些技术应用于肽激素生理学中涉及的其他亚细胞过程,如调节性分泌途径中的亚细胞运输和翻译后加工,同样令人印象深刻。例如,肽激素加工级联反应中的许多关键酶已被克隆,并正在分子水平上进行研究。由于已知的生理重要性、相互作用以及迄今为止完成的分析深度,我们将本文重点放在了生长抑素(SS)和胃泌素肽上。以SS和胃泌素为模型的研究确立了一些原则,涵盖了从基因活性的腔内调节到鉴定负责cAMP诱导SS基因表达的单个氨基酸残基的范围。胃肠道内分泌系统中的许多基因已被克隆,哈贝纳博士(本期其他地方)的文章讨论了在理解胰高血糖素基因复杂调控方面取得的进展。我们预计在胆囊收缩素、促胰液素、胃动素、血管活性肠肽、胰多肽和神经肽Y的研究中也会有类似进展,这些肽的基因已被克隆并初步表征。最后,如本文所述,即使在胃肠道内,特定基因的调控机制在表达位点之间也常常不同。对胃肠道内分泌细胞中调节基因表达和其他过程的亚细胞机制的直接研究等待着维持和培养这些细胞的新方法。这些研究几乎肯定会涉及重组分子生物学的新的创造性应用。